PHAXIAM Therapeutics S.A. Noncurrent Financial Liabilities
PHAXIAM Therapeutics S.A. had Noncurrent Financial Liabilities of EUR 14.38 million as of 2020-12-31, per its 20-F filed 2021-03-08.
Discontinued › Notes
ifrs-full:NoncurrentFinancialLiabilities · last filed 2021-03-08
- 2020-12-31: Noncurrent Financial Liabilities 14.38M EUR.
- 2020-06-30: Noncurrent Financial Liabilities 4.39M EUR.
- 2019-12-31: Noncurrent Financial Liabilities 1.32M EUR.
- 2019-06-30: Noncurrent Financial Liabilities 1.30M EUR.
| Period end | Noncurrent Financial Liabilities |
|---|---|
| 2020-12-31 | 14.38M EUR 20-F · filed 2021-03-08 |
| 2020-06-30 | 4.39M EUR 6-K · filed 2020-09-21 |
| 2019-12-31 | 1.32M EUR 20-F · filed 2021-03-08 |
| 2019-06-30 | 1.30M EUR 6-K · filed 2019-09-26 |
| 2018-12-31 | 1.24M EUR 20-F · filed 2021-03-08 |
| 2017-12-31 | 2.02M EUR 20-F · filed 2020-03-18 |
| 2016-12-31 | 2.82M EUR 20-F · filed 2019-03-29 |
| 2015-12-31 | 151.00K EUR 20-F/A · filed 2018-05-23 |